pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·2h ago·1 min read
save

Rock Health summit in San Francisco offers a mid-year health AI landscape check

Oct 15, 2026·read at Endpoints ↗Neutral

The author traveled to San Francisco to attend Rock Health's annual summit, noting it was the first visit in six months.

The event gathered health-technology leaders and investors, focusing on the latest developments in artificial intelligence applied to healthcare, providing a snapshot of current trends and challenges.

The author described the summit as a useful "gut check" on the pace of innovation, highlighting the mix of startups, established firms, and policy discussions shaping the sector's future.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “San Francisco's pulse on health AI”

read at Endpoints ↗
79 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoAstraZeneca does AI deal with insitro; inVIOs' Phase 1 success in solid tumorsEndpoints
  • 1h agoNorthStar's China CRO deal; Lonza details midterm guidanceEndpoints
  • 2h agoOsivax pivots to combo approach after flu jab fails in Phase 2bEndpoints
  • 2h agoOrbiMed raises $3B in new life sciences funds, including $1B+ for AsiaEndpoints
  • 3h agoAI will force doctors to focus on clinical reasoning, experts sayEndpoints